STUDY OF TWO DOSES OF DEXMEDETOMIDINE ON STRESS DURING INTUBATIO
Phase 4
- Conditions
- Health Condition 1: Z038- Encounter for observation for other suspected diseases and conditions ruled out
- Registration Number
- CTRI/2023/09/057767
- Lead Sponsor
- Dr Amanjot Singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients from 18-60 years of age of either gender
American Society of Anesthesiologists Grade I and II patients
Patients posted for elective surgery under general anaesthesia with endotracheal intubation
Exclusion Criteria
Patients with anticipated difficult intubation
Those requiring more than 15 seconds for intubation or more than one attempt at laryngoscopy
Patients allergic to dexmedetomidine
Patients on medications that affect heart rate
Pregnant patients
Patients undergoing emergency surgeries
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method optimal doses of dexmedetomidine in attenuating the haemodynamic response to laryngoscopy & edotracheal intubation.Timepoint: At baseline before infusion of study drug 5 minutes after end of drug infusion after induction just before intubation at 1 3 5 8 10 & 15 min after intubation
- Secondary Outcome Measures
Name Time Method HR, SBP, DBP , MAP & SpO2Timepoint: At baseline before infusion of study drug 5 minutes after end of drug infusion after induction just before intubation at 1 3 5 8 10 & 15 min after intubation